HOLOGIC THIRD QUARTER SALES PULSE AHEAD 65% TO $10.9 MIL.
This article was originally published in The Gray Sheet
Executive SummaryHOLOGIC THIRD QUARTER SALES PULSE AHEAD 65% TO $10.9 MIL., marking the firm's third consecutive profitable quarter and building on revenue increases of 40.6% and 54.1% during the first and second quarters, respectively, over the comparable year-ago periods. The third quarter sales also constitute a 10.5% increase over the second quarter, which was up 29.5% over the first quarter.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.